Expression and significance of T-cell immunoglobulin mucin molecule 3 and its ligand galectin-9 in patients with adenomyosis
This study investigated TIM-3 and Galectin-9 expression in endometrial tissue from adenomyosis patients, finding elevated levels in both eutopic and ectopic endometria compared to controls.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (29)
- Adenomyosis is a potential cause of recurrent implantation failure during IVF treatment via openalex
- Cytokine network of eutopic and ectopic endometrium in women with adenomyosis via openalex
- Decreased expression of killer cell inhibitory receptors on natural killer cells in eutopic endometrium in women with adenomyosis via openalex
- Estradiol and tamoxifen enhance invasion of endometrial stromal cells in a three-dimensional coculture model of adenomyosis via openalex
- Expression and possible role of interleukin-10 receptors in patients with adenomyosis via openalex
- Expression of interleukin-8 and monocyte chemotactic protein-1 in adenomyosis via openalex
- Is adenomyosis an immune disease? via openalex
- Pathogenesis and malignant transformation of adenomyosis (review) via openalex
- Risk factors for adenomyosis via openalex
- The distribution of immune cells and macrophages in the endometrium of women with recurrent reproductive failure. II: adenomyosis and macrophages via openalex
- W2107598346 via openalex
- W2108026478 via openalex
- W2111503975 via openalex
- W2122730216 via openalex
- W2149121521 via openalex
- W2151293773 via openalex
- W2154734098 via openalex
- W2159022177 via openalex
- W2167717479 via openalex
- W2979621416 via openalex
- W1785202715 via openalex
- W1930287693 via openalex
- W1968791512 via openalex
- W1992703894 via openalex
- W1996032846 via openalex
- W1998200605 via openalex
- W2030284622 via openalex
- W2070631889 via openalex
- W2093368037 via openalex
Cited by (9)
- The interaction between inflammation and estrogen in adenomyosis : from molecular mechanisms to therapeutic strategies 2026
- Additional file 1 of Vaginal microbiome differences between patients with adenomyosis with different menstrual cycles and healthy controls 2024
- Vaginal microbiome differences between patients with adenomyosis with different menstrual cycles and healthy controls 2024
- Additional file 1 of Vaginal microbiome differences between patients with adenomyosis with different menstrual cycles and healthy controls 2024
- Exosomes: potential diagnostic markers and drug carriers for adenomyosis 2023
- Characterising the immune cell phenotype of ectopic adenomyosis lesions compared with eutopic endometrium: A systematic review 2023
- Vaginal microbiome differences between patients with adenomyosis with different menstrual cycles and healthy controls 2023
- The Role of Platelets in the Pathogenesis and Pathophysiology of Adenomyosis 2023
- Vaginal microbiome of women with adenomyosis: A case-control study 2022
Source provenance
- europepmc
- last seen: 2026-10-10T06:11:15.153948+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-10-08T21:27:16.257658+00:00
- unpaywall
- last seen: 2026-10-10T06:25:47.132674+00:00